Home | About Us | News | Careers | Contact Us
 
 Eminentlabs™ Software Pvt Ltd
Industries Solutions Services Clients Programs
SIDDHA SYSTEM OF MEDICINE FOR PREVENTION AND CURE FOR COVID-19
Clinical Trials Checklist Pharma and Doctors Patient Management
   Administrative Information
       1. Title
       2. Trial Registration
       3. Protocol Version
       4. Funding
       5. Roles and Responsibilities

   Introduction
       6. Background and Rationale
       7. Objectives
       8. Trial Design

   Methods
     Participants, Interventions and Outcomes
       9. Study Setting
       10. Eligibility Criteria
       11. Interventions
       12. Outcomes
       13. Participant Timeline
       14. Sample Size
       15. Recruitment

    Assignment of interventions (for controlled trials)
       16. a. Allocation Sequence Generation
       16. b. Allocation Concealment
       16. c. Implementation
       17. Blinding (Masking)

     Data Collection, Management and Analysis
       18. Data Collection Methods
       19. Data Management
       20. Statistical Methods

     Monitoring
       21. Data Monitoring
       22. Harms
       23. Auditing

   Ethics and Dissemination
       24. Research Ethics Approval
       25. Protocol Amendments
       26. Consent or Assent
       27. Confidentially
       28. Declaration of Interests
       29. Access to data
       30. Ancillary and Post-trial Care
       31. Dissemination Policy

    Appendices
       32. Informed Consent Materials
       33. Biological Specimens
   Pharma

     COVID-19 Drugs
  1. GMP Licence
  2. OTC Drug
  3. Schedule E
   Doctors
  1. COVID-19: Protective Measures
  2. COVID-19: Functional Foods
  3. COVID-19 Stage 1 –Fever
  4. COVID-19 Stage 2 - Respiratory Illness
  5. COVID-19 Stage 3 - Viral Pneumonia


For Latest WHO Global Clinical Trial Status Click Here...

Please visit www.siddhaforcovid19.in for more details.

 Inclusion criteria:
  1. Male, Female and Transgenders
  2. Age between 18-70 years
  3. Individuals who tested positive for COVID-19
  4. Individual with travel history and/or suspected case-A or B, probable case A or B
  5. Subjects with symptoms of cough, fever, nasal congestion, body aches, sore throat, diarrhea
  6. Subjects willing to give informed consent for the study
  7. Subjects who are willing to take only Siddha drug regimen for COVID-19
Exclusion criteria:
  1. Patients who have other serious co-morbid conditions
  2. Stage-2 and stage-3 cases of COVID-19
  3. Vulnerable participants such as children, Pregnant and lactating mothers
  4. Subjects those who are not willing to give informed consent
Pandemic COVID-19
 
Email ID
Password
 
New User? Forgot Password?
SAP SE Walldorf Partnership
Eminentlabs™ Partners
ServiceFirst Swiss Partnership
Eminentlabs™ Partners
Eminentlabs Locations
Düsseldorf
Fritz-Vomfelde-Straße 34,
40547 Düsseldorf,
Germany
London
3 Crown Close, Brook Rd,
Buckhurst Hill IG9 5FE,
United Kingdom
Bangalore
#1213, 22nd Cross,
Sector 3, HSR Layout,
Bangalore,
India - 560 034
Chennai
#3466, TNHB,
AVADI, Chennai,
India - 600 054
 KPI Tracker™, ERPDS™, EWE™, eTracker™, eOutsource™, Rightshore™ are registered trademarks of Eminentlabs™ Software Private Limited